# Multiple Dose Safety Study of SRX251 Capsules in Healthy Volunteers

> **NCT00532467** · PHASE1 · COMPLETED · sponsor: **Azevan Pharmaceuticals** · enrollment: 50 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** SRX251

## Key facts

- **NCT ID:** NCT00532467
- **Lead sponsor:** Azevan Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-09
- **Primary completion:** 2008-02
- **Final completion:** 2008-02
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2008-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00532467

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00532467, "Multiple Dose Safety Study of SRX251 Capsules in Healthy Volunteers". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00532467. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*